Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Silverio

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Minerva Cardiology and Angiology|November 13, 2025
Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-complianceSalvatore Giordano, Francesco DE Stefano, Pasquale Campana, et al.
Journal of Clinical Medicine|April 28, 2023
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand?Michele Bellino, Gennaro Galasso, Angelo Silverio, et al.
Scientific Reports|April 22, 2020
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fractionMaria Vincenza Polito, Angelo Silverio, Antonella Rispoli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2020
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI RegistryAngelo Silverio, Rossella Maria Benvenga, Federico Piscione, et al.
JACC. Cardiovascular Imaging|September 14, 2015
Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo SyndromeRodolfo Citro, Eduardo Bossone, Guido Parodi, et al.
International Journal of Cardiology|July 9, 2016
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvementRodolfo Citro, Eduardo Bossone, Guido Parodi, et al.
Journal of Clinical Medicine|January 23, 2024
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible ComplicationsFrancesca Maria Di Muro, Chiara Cirillo, Luca Esposito, et al.
Heart (British Cardiac Society)|September 4, 2023
Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysisFrancesco Santoro, Scott Sharkey, Rodolfo Citro, et al.
European Journal of Clinical Investigation|August 20, 2020
Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational studyVincenzo Russo, Marco Di Maio, Filiberto Fausto Mottola, et al.
European Journal of Heart Failure|February 5, 2019
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fractionRodolfo Citro, Ilaria Radano, Guido Parodi, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Minerva Cardiology and Angiology|November 13, 2025
Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-complianceSalvatore Giordano, Francesco DE Stefano, Pasquale Campana, et al.
Journal of Clinical Medicine|April 28, 2023
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand?Michele Bellino, Gennaro Galasso, Angelo Silverio, et al.
Scientific Reports|April 22, 2020
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fractionMaria Vincenza Polito, Angelo Silverio, Antonella Rispoli, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2020
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI RegistryAngelo Silverio, Rossella Maria Benvenga, Federico Piscione, et al.
JACC. Cardiovascular Imaging|September 14, 2015
Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo SyndromeRodolfo Citro, Eduardo Bossone, Guido Parodi, et al.
International Journal of Cardiology|July 9, 2016
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvementRodolfo Citro, Eduardo Bossone, Guido Parodi, et al.
Journal of Clinical Medicine|January 23, 2024
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible ComplicationsFrancesca Maria Di Muro, Chiara Cirillo, Luca Esposito, et al.
Heart (British Cardiac Society)|September 4, 2023
Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysisFrancesco Santoro, Scott Sharkey, Rodolfo Citro, et al.
European Journal of Clinical Investigation|August 20, 2020
Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational studyVincenzo Russo, Marco Di Maio, Filiberto Fausto Mottola, et al.
European Journal of Heart Failure|February 5, 2019
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fractionRodolfo Citro, Ilaria Radano, Guido Parodi, et al.
Pageof 11